Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA
Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA
Andy Aguirre
Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
Angeliki Malliri
AstraZeneca, UK
Carla Martins
Charité, Berlin, Germany
Christine Sers
IRB, Barcelona, Spain
Direna Alonso
IBMCC-CIC, Salamanca, Spain
Esther Castellano
Department of Oncology - University of Turin - San Luigi hospital , Orbassano (TO) - Italy
Francesco Passiglia
University of California, San Francisco, USA
Frank McCormick
Revolution Medicince, USA
Jan Smith
VIB-VUB Center for Structural Biology, VIB & Vrije Universiteit Brussel, Brussels, Belgium
Jan Steyaert
Beaumont RCSI Cancer Centre, Dublin, Ireland
Jarushka Naidoo
Peter MacCallum Cancer Centre, Melbourne, Australia
Jayesh Desai
Francis Crick Institute, London, UK
Julian Downward
Brigham & Women's Hospital, Harvard Medical School, Boston, USA
Karen Cichowski
University of California, San Francisco, USA
Kevan Shokat
Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA
Kevin Haigis
University of Dundee, Dundee, UK
Kirsten McAulay
John Hopkins University School of Medicine, Baltimore, USA
Laura Wood
Max Perutz Labs, University of Vienna, Vienna BioCenter, Vienna, Austria
Manuela Baccarini
Center for Cancer Research, Medical University of Vienna
Maria Sibilia
CNIO, Madrid, Spain
Mariano Barbacid
Boehringer Ingelheim, Germany
Mark Pearson
Huntsman Cancer Institute, University of Utah, Salt Lake City, USA
Martin McMahon
Cancer Research UK, Cambridge, UK
Masashi Narita
Memorial Sloan Kettering Cancer Center, New York, USA
Piro Lito
NKI, Amsterdam, The Netherlands
René Bernards
Institut Gustave Roussy, Villejuif, France
Sophie de Carné
Memorial Sloan Kettering Cancer Center, New York, USA